REGENERON PHARMACEUTICALS, INC. Diversified Active

CIK: 0000872589 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 7, 2025

Total Value ($000): $700,445 (100.0% shares, 0.0% debt)

Holdings (4)

ALNY Alnylam Pharmaceuticals, Inc. 90.6%

Value ($000) $634,890 Shares 1,392,303 Est. Cost $262.99 Unrealized +54.8%

NTLA Intellia Therapeutics, Inc. 9.1%

Value ($000) $63,951 Shares 3,702,995 Est. Cost $15.61 Unrealized -21.1%

— Adverum Biotechnologies, Inc. 0.1%

Value ($000) $820 Shares 180,909 Est. Cost $4.67 Unrealized —

— Adicet Bio, Inc. 0.1%

Value ($000) $784 Shares 968,183 Est. Cost $0.96 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	1,392,303	$634,890	90.6%	$262.99	+54.8%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$63,951	9.1%	$15.61	-21.1%	Common Stock	45826J105
—	Adverum Biotechnologies, Inc.	180,909	$820	0.1%	$4.67	—	Common Stock	00773U207
—	Adicet Bio, Inc.	968,183	$784	0.1%	$0.96	—	Common Stock	007002108